How Is Acne Vulgaris Severity Graded Clinically, And What Limitations Of Traditional Acne Treatments Make Light-Based Phototherapy Systems A Preferred Alternative For Aesthetic Clinics?

Clinically, acne vulgaris is graded by lesion type, lesion count, inflammation, and the presence of nodules or scarring. A practical four-level framework describes mild acne as predominantly comedonal, moderate acne as having approximately 10–40 papules and pustules, moderately severe acne as including deeper nodules, and severe acne as extensive inflammatory and nodular disease. Light-based phototherapy is attractive to aesthetic clinics because it can address selected inflammatory and non-inflammatory lesions without systemic medication, antibiotic resistance, or the prolonged recovery associated with aggressive procedures.

The key point: Acne grading determines whether a light-based system is appropriate and how it should be used. Phototherapy is a useful non-drug or adjunctive option, particularly for non-cystic inflammatory acne, but it is not a universal replacement for dermatologic treatment or isotretinoin in severe nodulocystic disease.

How Acne Vulgaris Severity Is Graded

Mild acne

Mild acne is characterized mainly by open and closed comedones—blackheads and whiteheads—with fewer than approximately 10 papules or pustules.

There are no nodules in this category. The dominant problem is follicular plugging rather than deep inflammation.

Moderate acne

Moderate acne generally includes approximately 10–40 papules and pustules, together with a substantial comedonal burden.

The lesions are visibly inflammatory, but deep nodules are absent or not a major feature. This is often the range in which topical therapy, carefully selected procedures, or light-based treatment may be considered.

Moderately severe acne

Moderately severe acne includes fewer than approximately 40 papules and pustules, but may also contain up to five deeper nodular lesions.

The presence of nodules matters clinically because deeper inflammation increases the risk of persistent discoloration and scarring. Treatment should therefore be more deliberate than for uncomplicated comedonal acne.

Severe acne

Severe acne presents with numerous papules, pustules, and extensive nodular lesions.

Painful deep lesions, scarring, and marked inflammation are more likely. Severe or nodulocystic disease generally warrants medical assessment rather than reliance on an aesthetic light-based protocol alone.

Why Grading Is More Than Counting Lesions

Lesion type changes the treatment objective

Comedones reflect abnormal follicular keratinization and sebum retention. Papules and pustules indicate a stronger inflammatory component, while nodules reflect deeper involvement of the pilosebaceous unit.

A treatment that reduces superficial bacteria may help inflammatory lesions but have limited ability to resolve extensive deep nodules. This is why lesion depth and inflammation must be assessed alongside lesion number.

Scarring risk influences urgency

Inflammation can cause follicular rupture and damage surrounding tissue. As acne becomes deeper and more persistent, the risk of atrophic scars, hypertrophic scars, and post-inflammatory hyperpigmentation increases.

Clinicians should therefore grade not only current severity but also the patient’s scarring history, skin phototype, recurrence pattern, and response to previous treatment.

Grading systems are not completely uniform

The four-level framework is useful for clinical communication, but acne classification systems vary. Some describe Grade I as predominantly comedonal acne, Grade II as comedones with occasional papules and pustules, Grade III as numerous inflammatory lesions, and Grade IV as severe nodular or cystic disease.

These systems overlap conceptually rather than functioning as a single universally standardized scale. In practice, the most important distinctions are comedonal versus inflammatory disease, superficial versus nodular disease, and presence versus absence of scarring.

Why Traditional Acne Treatments Can Be Difficult to Use

Topical treatments can compromise tolerability

Topical retinoids, benzoyl peroxide, and topical antibiotics can cause dryness, irritation, erythema, peeling, or localized burning.

Some patients also develop allergic or irritant contact dermatitis. Poor tolerability can reduce adherence, which may make an otherwise effective regimen appear unsuccessful.

Antibiotics create resistance and systemic concerns

Topical and oral antibiotics can contribute to bacterial resistance, particularly when used repeatedly or without an appropriate non-antibiotic component.

The supporting evidence identifies substantial resistance among acne-associated organisms to commonly used macrolides and tetracyclines, although reported rates vary by organism, region, and study. Oral antibiotics may also cause gastrointestinal adverse effects and photosensitivity.

Isotretinoin requires careful medical management

Systemic isotretinoin can be highly effective for severe acne, but it carries significant safety and monitoring requirements.

Its most important limitation is teratogenicity. Other adverse effects and laboratory-monitoring considerations mean it is not an appropriate routine option for every patient or aesthetic-clinic setting.

Aggressive physical procedures can worsen pigmentation

Deep chemical peels and other aggressive resurfacing procedures may cause burning, prolonged erythema, crusting, or post-inflammatory hyperpigmentation.

Risk is particularly important in patients prone to pigmentary change. Treatment intensity must be matched to skin type, acne activity, and the clinician’s ability to manage complications.

How Light-Based Phototherapy Addresses Acne

Blue light targets bacterial porphyrins

Cutibacterium acnes, historically called Propionibacterium acnes, produces porphyrins during its metabolism.

Blue or violet light in an appropriate band—commonly around 420 nm—can activate these porphyrins and generate reactive oxygen species. This phototoxic process damages the bacteria without exposing the patient to an antibiotic and therefore does not create pharmacological antibiotic resistance.

Red light supports the inflammatory component

Red light is used for its deeper penetration and potential effects on inflammation and tissue response.

Dual blue-red protocols are therefore used in some systems to combine bacterial targeting with management of inflammatory lesions. Outcomes depend on wavelength, fluence, treatment schedule, device design, and patient selection.

Some systems affect sebum activity

Selected laser and light devices can deliver optical or thermal energy to the pilosebaceous unit.

Depending on the technology, this may reduce sebaceous activity or alter the follicular environment. These effects should not be assumed for every blue-light, red-light, IPL, or laser platform; the mechanism is device-specific.

Photodynamic therapy adds a photosensitizer

Photodynamic therapy, or PDT, combines a topical photosensitizing agent with targeted light exposure.

The photosensitizer increases light sensitivity in the treatment area, allowing activation of porphyrin-related phototoxic pathways and damage to acne-associated bacteria and inflamed tissue. PDT may be considered for more persistent inflammatory acne when the patient can accept several days of post-treatment downtime.

Why Clinics May Prefer Light-Based Systems

They are non-invasive and drug-free

For appropriately selected patients, phototherapy avoids systemic drug exposure and does not depend on antibiotic susceptibility.

This makes it useful for patients who cannot tolerate topical products, prefer to avoid oral medication, or have experienced inadequate results with antibiotic-based regimens.

They can reduce treatment-related barrier damage

Unlike many topical regimens, properly delivered light therapy does not continuously dry or peel the epidermis.

That does not mean it is risk-free, but it may be easier to integrate into a treatment plan for patients whose primary limitation is topical irritation.

They offer limited downtime with selected protocols

Standard non-invasive light treatments generally involve little downtime compared with deep peels or aggressive resurfacing.

PDT is different: it may produce erythema, crusting, transient hyperpigmentation, or several days of recovery. Its potential durability and intensity must be weighed against that downtime.

They can complement conventional care

Light-based treatment can function as a standalone option for selected non-cystic acne or as an adjunct to topical and medical therapy.

This is particularly relevant when a patient has failed conventional topical treatment, has concerns about systemic medication, or requires a non-antibiotic approach.

Understanding the Trade-offs

Phototherapy is not universally superior

“Preferred” should mean better suited to a specific patient and clinic objective, not automatically more effective than every conventional treatment.

Severe nodular, cystic, or scarring acne may require prescription therapy and specialist management. Delaying appropriate medical treatment in these cases can increase permanent scarring risk.

Results vary by technology and protocol

Blue light, red light, IPL, pulsed-dye lasers, and PDT do not have identical mechanisms or evidence.

A clinic should evaluate the device’s wavelength, energy settings, treatment schedule, skin-type considerations, contraindications, and clinical outcomes rather than treating all light-based systems as interchangeable.

Maintenance may be necessary

Phototherapy may reduce lesion counts without permanently correcting every driver of acne.

Sebum production, follicular hyperkeratinization, hormonal influences, and skincare practices can continue to promote recurrence. Patients may therefore require maintenance treatments or combination therapy.

Adverse effects remain possible

Light-based systems can cause transient erythema, warmth, dryness, pigmentary change, or—in more intensive protocols—crusting and inflammation.

Photosensitizing medications, active skin conditions, darker phototypes, recent tanning, and inadequate eye protection require particular attention during consultation and treatment planning.

PDT requires more careful scheduling

PDT can provide a stronger intervention than simple visible-light treatment, but it also introduces photosensitizer-related discomfort and recovery.

Protocols may use shorter incubation periods to reduce phototoxic effects, but treatment parameters must follow the device and photosensitizer manufacturer’s instructions and appropriate clinical protocols.

How to Apply This to Clinical Decision-Making

The most defensible approach is to match the device and protocol to acne severity, lesion depth, skin type, and treatment expectations.

If your primary focus is mild comedonal acne: Prioritize comedone-directed skincare and follicular management; use light-based treatment selectively rather than presenting it as a substitute for all topical therapy.
If your primary focus is moderate inflammatory acne: Consider blue or dual blue-red phototherapy as a non-drug or adjunctive option when irritation, adherence, or antibiotic exposure is a concern.
If your primary focus is persistent or antibiotic-resistant acne: Use phototherapy to reduce reliance on repeated antibiotic courses, while confirming that the device and protocol are appropriate for the acne phenotype.
If your primary focus is severe nodular or cystic acne: Refer for medical evaluation and use aesthetic light-based treatment only as an appropriately selected adjunct, not as a replacement for evidence-based systemic care.
If your primary focus is minimizing downtime and pigmentary complications: Favor conservative, non-invasive protocols and assess phototype, tanning history, photosensitizing drugs, and post-treatment care before treatment.

The right light-based system is not chosen by marketing category alone; it is chosen by matching a validated technology and protocol to the patient’s acne biology and clinical risk.

Summary Table:

Severity	Key Features	Suitable Light-Based Approach
Mild	Comedones (<10 papules/pustules)	Blue light for bacterial reduction
Moderate	10-40 papules/pustules	Blue/red light or IPL
Moderately Severe	<40 papules + up to 5 nodules	PDT or combination therapies
Severe	Numerous nodules & inflammation	Medical referral; PDT as adjunct

Enhance your clinic's acne treatment offerings with BELIS's advanced light-based systems, including IPL and PDT devices. Our professional-grade equipment is designed for clinics and premium salons seeking non-invasive, effective solutions. Contact us today to learn how BELIS can elevate your practice and meet the growing demand for safe, drug-free acne therapies. Contact us now!